DLL4 and neoplasm: Significantly, enhanced anti-tumor effects in preclinical models have been observed by combined inhibition of Dll4 and VEGF, and blockade of Dll4 was found to have potent growth inhibitory effects on some tumors that are resistant to VEGF inhibition.